Alzheimer's drug donanemab has been hailed as a 'turning point' for treatment. But what does it mean for people with the disease? - The Conversation
theconversation.comSubmitted by theconversationafrica5687 in health
The drug has been hailed as a ‘turning point’ in Alzheimer’s treatment. But keep in mind the trial only included participants with early or mild disease. And while it slowed decline, it’s not a cure.